Skip to main content
logo
CStone Pharmaceuticals (HKG:2616)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.190
-0.160 (-3.68%)
Jul 30, 2026, 4:08 PM HKT

CStone Pharmaceuticals Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
269.58269.58407.21463.84481.36243.72
Revenue Growth
33.13%-33.80%-12.21%-3.64%97.51%-76.54%
Gross Profit
51.2551.25240.15304.3278.38136.89
Operating Income
-415.83-415.83-95.36-579.16-912.15-1,829
Net Income
-437-437-91.21-367.23-902.68-1,920
Earnings Per Share
-0.31-0.31-0.07-0.29-0.77-1.65
EPS Growth
------

Revenue by Geography
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Mainland China
83.8483.84293.36370.23
Outside Mainland China
185.74185.74113.8593.61
Total
269.58269.58407.21463.84

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
962.49962.49719.881,0491,1481,779
Total Debt
348.52348.52355.97363.45286.29174.2
Net Cash (Debt)
613.97613.97363.91685.07861.311,604
Net Cash Growth
105.53%68.72%-46.88%-20.46%-46.32%-54.00%
Net Cash Per Share
0.440.440.290.540.731.38

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-327.75-327.75-303.21-588.84-610.74-1,484
Capital Expenditures
----0.02--91.03
Free Cash Flow
-327.75-327.75-303.21-588.86-610.74-1,575
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
19.01%19.01%58.98%65.60%57.83%56.17%
Operating Margin
-154.25%-154.25%-23.42%-124.86%-189.49%-750.64%
Pretax Margin
-157.26%-157.26%-22.40%-79.17%-187.53%-787.84%
Profit Margin
-162.10%-162.10%-22.40%-79.17%-187.53%-787.84%
FCF Margin
-121.58%-121.58%-74.46%-126.95%-126.88%-646.26%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
22.0314.08----
PS Ratio
23.1725.896.785.6710.1432.19